United Therapeutics
Clinical trials sponsored by United Therapeutics, explained in plain language.
-
New inhaled therapy aims to halt deadly lung scarring
Disease control Recruiting nowThis study tests if an inhaled drug called treprostinil can slow the decline in lung function for people with progressive pulmonary fibrosis (PPF), a condition where lung scarring worsens over time. About 698 adults with PPF will receive either the drug or a placebo for 52 weeks.…
Phase: PHASE3 • Sponsor: United Therapeutics • Aim: Disease control
Last updated Jun 15, 2026 18:54 UTC
-
Pig kidney transplant trial offers new hope for kidney patients
Disease control Recruiting nowThis study tests a genetically modified pig kidney (called the 10 GE Xenokidney) in 50 adults with end-stage kidney disease who cannot get a human kidney transplant or face a long wait. The goal is to see if the pig kidney works safely and well, improving survival and quality of …
Phase: PHASE1, PHASE2 • Sponsor: United Therapeutics • Aim: Disease control
Last updated Jun 15, 2026 18:54 UTC
-
Pig kidney trial offers new hope for kidney patients on long waitlists
Disease control Recruiting nowThis study tests whether a specially modified pig kidney can safely work in people with end-stage kidney disease who cannot get a human kidney transplant. Up to 50 participants will receive the pig kidney and be followed for life. The goal is to see if the pig kidney can keep pat…
Phase: PHASE1, PHASE2 • Sponsor: United Therapeutics • Aim: Disease control
Last updated Jun 10, 2026 13:26 UTC
-
New study to track lung and heart health in 900 patients
Knowledge-focused Recruiting nowThis study is a registry that will follow about 900 adults with both interstitial lung disease and pulmonary hypertension. Researchers will collect information on patients' medical history and track changes in their condition over time. The goal is to better understand these dise…
Sponsor: United Therapeutics • Aim: Knowledge-focused
Last updated Jun 22, 2026 12:08 UTC